Bessemer Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2M Buy
+137,993
New +$29.7M 0.05% 235
2026
Q1
Sell
-600
Closed -$124K 2563
2025
Q4
$124K Hold
600
﹤0.01% 1447
2025
Q3
$108K Hold
600
﹤0.01% 1260
2025
Q2
$97K Sell
600
-100
-14% -$15.9K ﹤0.01% 1220
2025
Q1
$119K Buy
700
+100
+17% +$17.4K ﹤0.01% 1178
2024
Q4
$100K Hold
600
﹤0.01% 1199
2024
Q3
$103K Hold
600
﹤0.01% 1278
2024
Q2
$92K Hold
600
﹤0.01% 1188
2024
Q1
$92K Hold
600
﹤0.01% 1194
2023
Q4
$95K Hold
600
﹤0.01% 1230
2023
Q3
$88K Hold
600
﹤0.01% 1235
2023
Q2
$92K Hold
600
﹤0.01% 1248
2023
Q1
$93K Hold
600
﹤0.01% 1094
2022
Q4
$92K Buy
+600
New +$88.5K ﹤0.01% 1056

Other funds holding FBT

Bessemer Group's FBT Position: Q2 2026 in Review

Bessemer Group opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 137,993 shares worth $34.2M. The stake represents 0.05% of the portfolio and ranks #235 among its holdings. This is a return to the name: Bessemer Group previously reported a position in FBT as recently as Q4 2025.

Bessemer Group first reported a position in FBT in Q4 2022 and has held it in 14 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Bessemer Group held 137,993 shares of First Trust NYSE Arca Biotechnology Index Fund worth $34.2M as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Bessemer Group position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Bessemer Group's portfolio in Q2 2026, its #235 holding.
  • Bessemer Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 14 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.